Archives of Virology

, Volume 163, Issue 10, pp 2711–2718 | Cite as

Association of CXCR2 genotype variations with HCV clearance in a Chinese population

  • Feng Zang
  • Ming Yue
  • Lingyun Zhuo
  • Jingjing Wu
  • Mei Liu
  • Yinan Yao
  • Jie Wang
  • Yue Feng
  • Xueshan Xia
  • Peng HuangEmail author
  • Rongbin YuEmail author
Original Article


Chemokines are known to play a vital role in guiding and regulating the immune response to viral infections. The chemokine CXC subfamily is a major subfamily in the chemokine family. Outcomes of hepatitis C virus (HCV) infection, as well as the response to treatment, depend on virus and host factors. Here we recruited chronic hepatitis C (CHC) patients to perform an association study between three single nucleotide polymorphisms (SNPs) (CXCR2 rs1126579, CXCL10 rs8878 and CXCL10 rs3921) and HCV infection outcomes and treatment responses among a Chinese population, using primarily a TaqMan assay. Multivariate logistic regression analysis was performed to identify the influencing factors on HCV infection outcome and treatment response. The results showed that subjects with the CXCR2 rs1126579 TT genotype had a significantly increased possibility of HCV spontaneous clearance (Dominant model: adjusted OR = 1.32, 95% CI = 1.06-1.64; P = 0.013). Additionally, CHC patients carrying the CXCR2 rs1126579 TT genotype were also more likely to achieve a sustained virological response (SVR) (Dominant model: adjusted OR = 0.49, 95% CI = 0.29-0.84; P = 0.010). We also established a predictive model for HCV treatment response including the CXCR2 rs1126579 SNP status, albumin (ALB) levels and baseline HCV RNA levels, which produced an area under the curve (AUC) of about 0.660. These findings highlight that variant CXCR2 rs1126579 genotypes are associated with HCV clearance within the Chinese population.


Author contributions

FZ, PH and RY participated in the design of the study. FZ and MY carried out the surveys and experiments. FZ performed the statistical analysis. LZ, JW, ML and YY contributed materials and analysis tools. FZ wrote the paper. All authors read and approved the final manuscript.


The current study was supported in part by National Natural Science Foundation of China (No. 81473029, 81703273, 81502853, 81473028), Natural Science Foundation of Jiangsu Province (BK2017041691, BK20151026), the Science and Technology Development Fund Key Project of Nanjing Medical University (2016NJMUZD012), Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).

Compliance with ethical standards

Conflicts of interest

The authors declare no conflict of interest.

Ethical approval

This study was approved by the Ethics Committee of Nanjing Medical University.

Informed consent

All subjects were provided the voluntary informed consent to participate in the study.

Supplementary material

705_2018_3872_MOESM1_ESM.doc (36 kb)
Supplementary material 1 (DOC 35 kb)


  1. 1.
    Ansari MA et al (2017) Genome-to-genome analysis highlights the effect of the human innate and adaptive immune systems on the hepatitis C virus. Nat Genet 49(5):666–673CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    Qin G et al (2016) Population-representative incidence of acute-on-chronic liver failure: a prospective cross-sectional study. J Clin Gastroenterol 50(8):670–675CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Estrabaud E et al (2012) Genomics and HCV infection: progression of fibrosis and treatment response. J Hepatol 57(5):1110–1125CrossRefPubMedGoogle Scholar
  4. 4.
    Zeremski M, Petrovic LM, Talal AH (2007) The role of chemokines as inflammatory mediators in chronic hepatitis C virus infection. J Viral Hepat 14(10):675–687PubMedGoogle Scholar
  5. 5.
    Miller MC, Mayo KH (2017) Chemokines from a structural perspective. Int J Mol Sci 18(10):2088CrossRefPubMedCentralGoogle Scholar
  6. 6.
    Lazennec G, Richmond A (2010) Chemokines and chemokine receptors: new insights into cancer-related inflammation. Trends Mol Med 16(3):133–144CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Allen SJ, Crown SE, Handel TM (2007) Chemokine: receptor structure, interactions, and antagonism. Annu Rev Immunol 25:787–820CrossRefPubMedGoogle Scholar
  8. 8.
    Jimenez-Sousa MA et al (2017) CXCL9-11 polymorphisms are associated with liver fibrosis in patients with chronic hepatitis C: a cross-sectional study. Clin Transl Med 6(1):26CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    Thrift AP, El-Serag HB, Kanwal F (2017) Global epidemiology and burden of HCV infection and HCV-related disease. Nat Rev Gastroenterol Hepatol 14(2):122–132CrossRefPubMedGoogle Scholar
  10. 10.
    Lanini S et al (2016) Hepatitis C: global epidemiology and strategies for control. Clin Microbiol Infect 22(10):833–838CrossRefPubMedGoogle Scholar
  11. 11.
    World Health Organization (2017) World health statistics 2017: monitoring health for the SDGs, sustainable development goals. World Health Organization, GenevaGoogle Scholar
  12. 12.
    World Health Organization (2017) Global hepatitis report 2017. World Health Organization, GenevaGoogle Scholar
  13. 13.
    Duggal P et al (2013) Genome-wide association study of spontaneous resolution of hepatitis C virus infection: data from multiple cohorts. Ann Intern Med 158(4):235–245CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Rauch A, Rohrbach J, Bochud PY (2010) The recent breakthroughs in the understanding of host genomics in hepatitis C. Eur J Clin Investig 40(10):950–959CrossRefGoogle Scholar
  15. 15.
    Dimberg J et al (2014) Protein expression and gene polymorphism of CXCL10 in patients with colorectal cancer. Biomed Rep 2(3):340–343CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Klich I et al (2011) Effect of the IP10 (CXCL10) and HLA genotype on the risk of type 1 diabetes in children. Pediatr Endocrinol Diabetes Metab 17(1):10–13PubMedGoogle Scholar
  17. 17.
    Kotrych D et al (2015) CXCL9 and CXCL10 gene polymorphisms in patients with rheumatoid arthritis. Rheumatol Int 35(8):1319–1323CrossRefPubMedGoogle Scholar
  18. 18.
    Hoh BP et al (2015) Common variants of chemokine receptor gene CXCR3 and its ligands CXCL10 and CXCL11 associated with vascular permeability of dengue infection in peninsular Malaysia. Hum Immunol 76(6):421–426CrossRefPubMedGoogle Scholar
  19. 19.
    Falconer K et al (2008) Spontaneous HCV clearance in HCV/HIV-1 coinfection associated with normalized CD4 counts, low level of chronic immune activation and high level of T cell function. J Clin Virol 41(2):160–163CrossRefPubMedGoogle Scholar
  20. 20.
    Osburn WO et al (2013) Anti-inflammatory cytokines, pro-fibrogenic chemokines and persistence of acute HCV infection. J Viral Hepat 20(6):404–413CrossRefPubMedGoogle Scholar
  21. 21.
    Pineda-Tenor D et al (2015) Single nucleotide polymorphisms of CXCL9-11 chemokines are associated with liver fibrosis in HIV/HCV-coinfected patients. J Acquir Immune Defic Syndr 68(4):386–395CrossRefPubMedGoogle Scholar
  22. 22.
    Aschebrook-Kilfoy B et al (2012) Polymorphisms in immune function genes and non-Hodgkin lymphoma survival. J Cancer Surviv 6(1):102–114CrossRefPubMedGoogle Scholar
  23. 23.
    Xu R et al (2016) Low expression of CXCR1/2 on neutrophils predicts poor survival in patients with hepatitis B virus-related acute-on-chronic liver failure. Sci Rep 6:38714CrossRefPubMedPubMedCentralGoogle Scholar
  24. 24.
    Timasheva YR, Nasibullin TR, Mustafina OE (2015) The CXCR2 gene polymorphism is associated with stroke in patients with essential hypertension. Cerebrovasc Dis Extra 5(3):124–131CrossRefPubMedPubMedCentralGoogle Scholar
  25. 25.
    Ryan BM et al (2015) Identification of a functional SNP in the 3’UTR of CXCR2 that is associated with reduced risk of lung cancer. Cancer Res 75(3):566–575CrossRefPubMedGoogle Scholar
  26. 26.
    Citro A et al (2015) CXCR1/2 inhibition blocks and reverses type 1 diabetes in mice. Diabetes 64(4):1329–1340CrossRefPubMedGoogle Scholar
  27. 27.
    Chen M et al (2017) Polymorphisms of chemokine receptor genes and clearance of hepatitis C virus infection in Chinese population. Gene 624:1–5CrossRefPubMedGoogle Scholar
  28. 28.
    Sun HQ et al (2014) The new pattern of drug abuse in China. Curr Opin Psychiatry 27(4):251–255CrossRefPubMedGoogle Scholar
  29. 29.
    Bi HJ et al (2012) Influence of IFN on expression of chemokine receptor CXCR1, CXCR2 and their ligand IL-8 in the patients with chronic hepatitis B. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 28(4):422–425PubMedGoogle Scholar
  30. 30.
    Yuan G et al (2017) Genotype distribution and molecular epidemiology of hepatitis C virus in Guangzhou, China: predominance of genotype 1b and increasing incidence of genotype 6a. Cell Physiol Biochem 43(2):775–787CrossRefPubMedGoogle Scholar
  31. 31.
    Li XM et al (2017) Genotype and genetic variation of HCV infections with low-risk factors in Putian coastal regions, China. Epidemiol Infect 2017:1–13CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Austria, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Epidemiology and Biostatistics, School of Public Health, Key Laboratory of Infectious DiseasesNanjing Medical UniversityNanjingChina
  2. 2.Department of Infectious DiseasesThe First Affiliated Hospital of Nanjing Medical UniversityNanjingChina
  3. 3.Department of Basic and Community Nursing, School of NursingNanjing Medical UniversityNanjingChina
  4. 4.Faculty of Life Science and TechnologyKunming University of Science and TechnologyKunmingChina

Personalised recommendations